Cysticercosis: An emerging parasitic disease

American Family Physician

Volumn 76, Issue 1, 2007, Pages

  Kraft, Robert ^a  

^a Smoky Hill Family Medicine Residency Program   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALBENDAZOLE; ANTHELMINTIC AGENT; ANTICONVULSIVE AGENT; ANTIPARASITIC AGENT; CARBAMAZEPINE; MANNITOL; PHENYTOIN; PRAZIQUANTEL; STEROID;

BRAIN EDEMA; CESTODE; CLINICAL FEATURE; CLINICAL TRIAL; COMPUTER ASSISTED TOMOGRAPHY; DISEASE CONTROL; DRUG EFFICACY; ENDEMIC DISEASE; HUMAN; INCIDENCE; MUSCLE TUMOR; NEUROCYSTICERCOSIS; NUCLEAR MAGNETIC RESONANCE IMAGING; PARASITOSIS; REVIEW; SEIZURE; SURGICAL TECHNIQUE;

ANIMALS; ANTIPARASITIC AGENTS; CYSTICERCOSIS; DIAGNOSIS, DIFFERENTIAL; DIAGNOSTIC IMAGING; HUMANS; SWINE; TAENIA SOLIUM;

EID: 34447134049     PISSN: 0002838X     EISSN: 0002838X     Source Type: Journal    
DOI: None     Document Type: Review

References (31)

1. Castillo M. Imaging of neurocysticercosis. Semin Roengenol 2004;39:465-73.
2. Hawk MW, Shahlaie K, Kim KD, Theis JH. Neurocysticercosis: a review. Surg Neurol 2005;63:123-32.
3. Psarros TG, Zouros A, Coimbra C. Neurocysticercosis: a neurosurgical perspective. South Med J 2003;96:1019-22.
4. Garcia HH, Del Brutto OH. Taenia solium cysticercosis. Infect Dis Clin North Am 2000;14:97-119.
5. Sawhney IM, Singh G, Lekhra OP, Mathuriya SN, Parihar PS, Prabhakar S. Uncommon presentations of neurocysticercosis. J Neurol Sci 1998;154:94-100.
6. Proaño JV, Madrazo I, García L, García-Torres E, Correa D. Albendazole and praziquantel treatment in neurocysticercosis of the fourth ventricle. J Neurosurg 1997;87:29-33.
7. Garcia HH, Gonzalez AE, Evans CA, Gilman RH, for the Cysticercosis Working Group in Peru. Taenia solium cysticercosis. Lancet 2003;362:547-56.
8. Shandera WX, White AC Jr, Chen JC, Diaz P, Armstrong R. Neurocysticercosis in Houston, Texas. A report of 112 cases. Medicine (Baltimore) 1994;73:37-52.
9. Singhi P, Singhi S. Neurocysticercosis in children. J Child Neurol 2004;19:482-92.
10. Del Brutto OH, Roos KL, Coffey CS, Garcia HH. Meta-analysis: cysticidal drugs for neurocysticercosis: albendazole and praziquantel. Ann Intern Med 2006;145:43-51.
11. Del Brutto OH, Santibañez R, Noboa CA, Aguirre R, Diaz E, Alarcón TA. Epilepsy due to neurocysticercosis: analysis of 203 patients. Neurology 1992;42:389-92.
12. Garcia HH, Evans CA, Nash TE, Takayanagui OM, White AC Jr, Botero D, et al. Current consensus guidelines for treatment of neurocysticercosis. Clin Microbiol Rev 2002;15:747-56.
13. García HH, Pretell EJ, Gilman RH, Martinez SM, Moulton LH, Del Brutto OH, et al. A trial of antiparasitic treatment to reduce the rate of seizures due to cerebral cysticercosis. N Engl J Med 2004;350:249-58.
14. Ong S, Talan DA Moran GJ, Mower W, Newdow M, Tsang VC, et al., for the EMERGEncy ID NET study group. Neurocysticercosis in radiographically imaged seizure patients in U.S. emergency departments. Emerg Infect Dis 2002;8:608-13.
15. Nash TE, Del Brutto OH, Butman JA, Corona T, Delgado-Escueta A, Duron RM, et al. Calcific neurocysticercosis and epileptogenesis. Neurology 2004;62:1934-8.
16. Sharma T, Sinha S, Shah N, Gopal L, Shanmugam MP, Bhende P, et al. Intraocular cysticercosis: clinical characteristics and visual outcome after vitreoretinal surgery. ophthalmology 2003;110:996-1004.
17. Martinez HR, Rangel-Guerra R, Arredondo-Estrada JH, Marfil A, Onofre J. Medical and surgical treatment in neurocysticercosis a magnetic resonance study of 161 cases. J Neurol Sci 1995;130:25-34.
18. Sá DS, Teive HA, Troiano AR, Werneck LC. Parkinsonism associated with neurocysticercosis. Parkinsonism Relat Disord 2005;11:69-72.
19. Proaño JV, Madrazo I, Avelar F, López-Félix B, Díaz G, Grijalva I. Medical treatment for neurocysticercosis characterized by giant subarachnoid cysts. N Engl J Med 2001;345:879-85.
20. Mohan K, Saroha V, Sharma A, Pandav S, Singh U. Extraocular muscle cysticercosis: clinical presentations and outcome of treatment. J Pediatr ophthalmol Strabismus 2005;42:28-33.
21. Del Brutto OH, Wadia NH, Dumas M, Cruz M, Tsang VC, Schantz PM. Proposal of diagnostic criteria for human cysticercosis and neurocysticercosis. J Neurol Sci 1996;142:1-6.
22. Del Brutto OH, Rajshekhar V, White AC Jr, Tsang VC, Nash TE, Takayanagui OM, et al. Proposed diagnostic criteria for neurocysticercosis. Neurology 2001;57:177-83.
23. Rajshekhar V, Chandy MJ. Validation of diagnostic criteria for solitary cerebral cysticercus granuloma in patients presenting with seizures. Acta Neurol Scand 1997;96:76-81.
24. Sundaram PM, Jayakumar N, Noronha V. Extraocular muscle cysticercosis - a clinical challenge to the ophthalmologists. Orbit 2004;23:255-62.
25. Diaz JF, Verastegui M, Gilman RH, Tsang VC, Pilcher JB, Gallo C, et al. Immunodiagnosis of human cysticercosis (Taenia solium): a field comparison of antibody-enzyme-linked immunosorbent assay (ELISA), an antigen-ELISA, and an enzyme-linked immunoelectrotransfer blot (EITB) assay in Peru. Am J Trop Med Hyg 1992;46:610-5.
26. Gongora-Rivera F, Soto-Hernandez JL, Gonzalez Esquivel D, Cook HJ, Marquez-Caraveo C, Hernandez Davila R, et al. Albendazole trial at 15 or 30 mg/kg/day for subarachnoid and intraventricular cysticercosis. Neurology 2006;66:436-8.
27. Singhi P, Dayal D, Khandelwal N. One week versus four weeks of albendazole therapy for neurocysticercosis in children: a randomized, placebo-controlled double blind trial. Pediatr Infect Dis J 2003;22:268-72.
28. García HH, Gilman RH, Horton J, Martinez M, Herrera G, Altamirano J, et al. Albendazole therapy for neurocysticercosis: a prospective double-blind trial comparing 7 versus 14 days of treatment. Neurology 1997;48:1421-7.
29. Figueroa JP. Report of the Workgroup on Parasitic Diseases. MMWR Morb Mortal Weekly Rep 1999;48(SU01):118-25. Accessed January 31, 2007, at: http://www.cdc.gov/mmwr/preview/mmwrhtml/su48a21.htm.
30. Guo A, Jin Z, Zheng Y, Hai G, Yuan G, Li H, et al. Induction of protection against porcine cysticercosis in growing pigs by DNA vaccination. Vaccine 2007;25:170-5.
31. Yancey LS, Diaz-Marchan PJ, White AC. Cysticercosis: recent advances in diagnosis and management of neurocysticercosis. Curr Infect Dis Rep 2005;7:39-47.